Development of an extracellular matrix delivery system for effective intramyocardial injection in ischemic tissue

ASAIO Journal

Volumn 60, Issue 6, 2014, Pages 730-736

  Slaughter, Mark S ^a,b   Soucy, Kevin G ^a,b   Matheny, Robert G ^c   Lewis, Beecher C ^c   Hennick, Michael F ^c   Choi, Young ^b   Monreal, Gretel ^a   Sobieski, Michael A ^a,b   Giridharan, Guruprasad A ^b   Koenig, Steven C ^a,b  

^a Cardiovascular Innovation Institute   (United States)

^b University of Louisville   (United States)

^c CorMatrix Cardiovascular Inc Roswell ^*  (United States)

Author keywords

Biomaterials; Cardiac regeneration; ECM; Heart failure; Injection device

Indexed keywords

ENZYME INHIBITION; PATIENT TREATMENT;

AUTOMATED INJECTION; CARDIAC FUNCTIONS; EXTRACELLULAR MATRICES; INJECTION PRESSURES; ISCHEMIC TISSUES; MEASUREMENT SYSTEM; PORTABLE ULTRASOUND; SMALL INTESTINAL SUBMUCOSA;

TISSUE;

ANTIARRHYTHMIC AGENT; BIOMATERIAL; POLYETHYLENE; CARDIOVASCULAR AGENT;

ANIMAL EXPERIMENT; ARTICLE; AUTOPSY; BLEEDING; BOVINE MODEL; EXTRACELLULAR MATRIX; GENERAL MEDICAL DEVICE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; SYRINGE; ANIMAL; BOVINE; DEVICES; DISEASE MODEL; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; EVALUATION STUDY; INJECTION; INTRAOPERATIVE PERIOD; MALE; MATERIALS TESTING; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; REGENERATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARDIOVASCULAR AGENTS; CATTLE; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; EXTRACELLULAR MATRIX; INJECTIONS; INTRAOPERATIVE PERIOD; MALE; MATERIALS TESTING; MYOCARDIAL ISCHEMIA; REGENERATION; SWINE;

EID: 84927699202     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000146     Document Type: Article

References (33)

1. Okada M, Payne TR, Oshima H, Momoi N, Tobita K, Huard J: Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials 31: 7678-7683, 2010.
2. Sutton MG, Sharpe N: Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981-2988, 2000.
3. Anversa P, Li P, Zhang X, et al.: Ischaemic myocardial injury and ventricular remodeling. Cardiovasc Res 27: 145-157, 1993.
4. Spinale FG, Janicki JS, Zile MR: Membrane-associated matrix proteolysis and heart failure. Circ Res 112: 195-208, 2013.
5. Lindsey ML, Mann DL, Entman ML, Spinale FG: Extracellular matrix remodeling following myocardial injury. Ann Med 35:316-326, 2003.
6. Kirklin JK, Naftel DC, Kormos RL, et al: Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32: 141-156, 2013.
7. Soucy KG, Koenig SC, Giridharan GA, et al.: Rotary pumps and diminished pulsatility: Do we need a pulse? ASAIO J 59: 355-366, 2013.
8. Heidenreich PA, Lin S, Knowles JW, et al: Variation in use of left ventriculography in the Veterans Affairs Health Care System. Circ Cardiovasc Qual Outcomes 6: 687-693, 2013.
9. Birks EJ: Molecular changes after left ventricular assist device support for heart failure. Circ Res 113: 777-791, 2013.
10. Drakos SG, Kfoury AG, Selzman CH, et al: Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol 26: 245-255, 2011.
11. Christman KL, Lee RJ: Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48: 907-913, 2006.
12. Nelson DM, Ma Z, Fujimoto KL, Hashizume R, Wagner WR: Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater 7: 1-15, 2011.
13. Singelyn JM, Christman KL: Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res 3: 478-486, 2010.
14. Daniel J, Abe K, McFetridge PS: Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO J 51: 252-261, 2005.
15. Badylak S, Obermiller J, Geddes L, Matheny R: Extracellular matrix for myocardial repair. Heart Surg Forum 6: E20-E26, 2003.
16. Rosen M, Roselli EE, Faber C, Ratliff NB, Ponsky JL, Smedira NG: Small intestinal submucosa intracardiac patch: an experimental study. Surg Innov 12: 227-231, 2005.
17. Zhao ZQ, Puskas JD, Xu D, et al: Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. J Am Coll Cardiol 55: 1250-1261,2010.
18. Toeg HD, Tiwari-Pandey R, Seymour R, et al: Injectable small intestine submucosal extracellular matrix in an acute myocardial infarction model. Ann Thorac Surg 96: 1686-1694, 2013.
19. Kochupura PV, Azeloglu EU, Kelly DJ, et al: Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 112(suppl 9): I144-I149, 2005.
20. Robinson KA, Li J, Mathison M, et al: Extracellular matrix scaffold for cardiac repair. Circulation 112(suppl 9): I135-I143, 2005.
21. Kornowski R, Leon MB, Fuchs S, et al: Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy: Results in normal and ischemic porcine models. J Am Coll Cardiol 35: 1031-1039, 2000.
22. Freyman T, Polin G, Osman H, et al: A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27: 1114-1122, 2006.
23. Perin EC, Silva GV, Assad JA, et al: Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 44: 486-495, 2008.
24. McCall FC, Telukuntla KS, Karantalis V, et al: Myocardial infarction and intramyocardial injection models in swine. Nat Protoc 7:1479-1496, 2012.
25. Sherman W, Martens TP, Viles-Gonzalez JF, Siminiak T: Catheter-based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med 3(suppl 1): S57-S64, 2006.
26. Bartoli CR, Sherwood LC, Giridharan GA, et al: Bovine model of chronic ischemic cardiomyopathy: implications for ventricular assist device research. Artif Organs 37: E202-E214, 2013.
27. Sherwood LC, Sobieski MA, Koenig SC, Giridharan GA, Slaughter MS: Benefits of aggressive medical management in a bovine model of chronic ischemic heart failure. ASAIO J 59: 221-229, 2013.
28. Perin EC, Dohmann HF, Borojevic R, et al: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107: 2294-2302, 2003.
29. Smits PC, van Geuns RJ, Poldermans D, et al.: Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J Am Coll Card 42: 2063-2069, 2003
30. Lunde K, Solheim S, Aakhus S, et al: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355: 1199-1209, 2006.
31. Leor J, Tuvia S, Guetta V, et al: Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol 54:1014-1023, 2009.
32. Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM: Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 114:2627-2635, 2006.
33. Wenk JF, Wall ST, Peterson RC, et al: A method for automatically optimizing medical devices for treating heart failure: designing polymeric injection patterns. J Biomech Eng 131: 121011, 2009.